Colleen Taralson
YOU?
Author Swipe
View article: Safety and Real-World Effectiveness in the Transition from Alteplase to Tenecteplase for Stroke Treatment
Safety and Real-World Effectiveness in the Transition from Alteplase to Tenecteplase for Stroke Treatment Open
Background: Tenecteplase has been shown to be non-inferior to alteplase for the treatment of acute ischemic stroke within 4.5 hours of stroke onset. While not formally approved by regulatory authorities, many jurisdictions have transitione…
View article: Workflow and Short-Term Functional Outcomes in Simultaneous Acute Code Stroke Activation and Stroke Reperfusion Therapy
Workflow and Short-Term Functional Outcomes in Simultaneous Acute Code Stroke Activation and Stroke Reperfusion Therapy Open
The burden of simultaneous acute code stroke activation (ACSA) is not known. We aim to assess the effect of simultaneous ACSA on workflow metrics and home time at 90 days in patients undergoing reperfusion therapies in the emergency depart…
View article: B.2 Short-term outcome in simultaneous acute code stroke activations in the emergency department
B.2 Short-term outcome in simultaneous acute code stroke activations in the emergency department Open
Background: We aim to assess the effect of simultaneous acute code stroke activation(ACSA) in patients undergoing reperfusion therapies in the emergency department on home time at 90 days. Methods: We assessed ACSA over 20 months from the …